☆ 4.7 Letter

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

ANNALS OF THE RHEUMATIC DISEASES (2021)

Get Full Text
Add to Collection

Journal

ANNALS OF THE RHEUMATIC DISEASES
Volume 80, Issue 8, Pages 1098-1099

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2021-220289

Keywords

COVID-19; vaccination; autoimmune diseases; antirheumatic agents

Categories

Rheumatology

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [F32DK124941, K23DK115908]
  2. National Institute of Allergy and Infectious Diseases (NIAID) [K24AI144954]
  3. NIAMS [K23AR073927]
  4. Transplantation and Immunology Research Network of the American Society of Transplantation (Werbel) [gSAN-201C0WW]
  5. Ben-Dov family

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.